TITLE

Peptic Ulcer Bleeding: Comparison of Two Hemostatic Procedures

AUTHOR(S)
Buffoli, F.; Graffeo, M.; Nicosia, F.; Gentile, C.; Cesari, P.; Rolfi, F.; Paterlini, A.
PUB. DATE
January 2001
SOURCE
American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p89
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Bleeding is a serious complication of peptic ulcer. Endoscopic injection therapy is accepted as a homeostatic endoscopic treatment in acute nonvariceal of upper GI hemorrhages, particularly in bleeding peptic ulcers. The risk of rebleeding is predicted by the endoscopic appearance of ulcer features classified according to Forrest's criteria. METHODS: Two hundred twenty-three patients were selected from 1.003 emergency upper endoscopies for GI bleeding. According to Forrest's criteria, 99 well-matched patients with ulcers FI and F2 were considered at risk of rebleeding; 54 patients (group A) received local ulcer injection of epinephrine solution 1:10.000. whereas (group B) patients were treated with local epinephrine injection and then with endoscopic Hemoclips. We considered the control of bleeding, the number of rebleeding episodes, the need for emergency surgery, and mortality. RESULTS: Bleeding ulcers stopped completely in 83.3% group A patients, and in 95.6% group B patients (p = not significant). In a subset of Fib patients the rebleeding rate was 31 % for group A and 0% for group B (p < 0.05). There was no mortality as a result of the procedure. There was a trend toward reducing surgery in favor of the combined therapy (0% vs 7.4%). No differences were found in transfusion requirements or mean hospitalization days. CONCLUSIONS: We conclude that endoscopic injection of 1:10.000 epinephrine solution alone and epinephrine solution plus application of Hemoclips are equivalent therapies in treating bleeding and rebleeding from peptic ulcers. There was no difference between therapies in terms of need for surgery or mortality. Possibly combination therapy is more effective in treating ulcers that are actively oozing.
ACCESSION #
17635135

 

Related Articles

  • Long-term Follow-up of Endoscopic Treatment for Bleeding Gastric and Duodenal Ulcers. Inadomi, John; Koch, Johannes; Cello, John P. // American Journal of Gastroenterology;Jul1995, Vol. 90 Issue 7, p1065 

    Objective: To examine the long-term consequences of endoscopic therapy for bleeding peptic ulcers. Methods: Eighty-seven consecutive patients who underwent endoscopic treatment for bleeding gastric ulcer (GU) and/or duodenal ulcer (DU) over a 42-month period were identified. Long-term follow-up...

  • Active, Bleeding Marginal Ulcer of Billroth II Gastric Resection: A Clinical Experience of 18 Patients. Jeng-Shiann Shin; Kuan-Wen Chen; Xi-Zhang Lin; Ching-Yih Lin; Ting-Tsang Chang; Chi-Chieh Yang // American Journal of Gastroenterology;Oct1994, Vol. 89 Issue 10, p1831 

    Objectives: From July 1988 to April 1993, 18 patients with active, marginal ulcer bleeding were investigated for their clinical presentation, endoscopic findings, and successful rate of therapeutic endoscopy. Methods: Through endoscopic survey, data on the ulcer number, ulcer location, and...

  • Editorial: Upper GI Bleeding–Associated Mortality: Challenges To Improving A Resistant Outcome. Lanas, Angel // American Journal of Gastroenterology;Jan2010, Vol. 105 Issue 1, p90 

    Although the incidence of peptic ulcer bleeding (PUB) has decreased, mortality has remained constant despite the advances in endoscopic and pharmacological therapies. Recent data indicate that most PUB-linked deaths are not direct sequelae of the bleeding ulcer itself. Instead, mortality derives...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • Combination Treatment for Peptic Ulcers at High Risk for Recurrent Bleeding. Sung, J.J.Y.; Chan, F.K.L.; Lau, J.Y.W.; Yung, M.-Y.; Leung, W.-K.; Wu, J.C.Y.; Ng, E.K.W.; Chung, S.C.S. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, pI12 

    Focuses on combination treatment for peptic ulcers at high risk for recurrent bleeding. Definition of peptic ulcers; Form of treatment that stop active bleeding and prevent recurrent bleeding; Drugs involved in endoscopic treatment of blood vessel.

  • The Effect of Endoscopic Therapy in Patients Receiving Omeprazole for Bleeding Ulcers with Nonbleeding Visible Vessels or Adherent Clots. Sung, Joseph J.Y.; Chan, Francis K.L.; Lau, James Y.W.; Man-Yee Yung; Wai-Keung Leung; Wu, Justin C.Y.; Ng, Enders K.W.; Sydney Chung, S.C. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, p237 

    Focuses on the effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Effect of endoscopic treatment on bleeding from peptic ulcers; Different approaches of treating bleeding from a peptic ulcer patients; Method of...

  • Diabetes and 30-Day Mortality From Peptic Ulcer Bleeding and Perforation. Thomsen, Reimar W.; Riis, Anders; Christensen, Steffen; Nørgaard, Mette; Sørensen, Henrik T. // Diabetes Care;Apr2006, Vol. 29 Issue 4, p805 

    OBJECTIVE -- Diabetes may influence the outcome of complicated peptic ulcer disease, due to angiopathy, blurring of symptoms, and increased risk of sepsis. We examined whether diabetes increased 30-day mortality among Danish patients hospitalized with bleeding or perforated peptic ulcers....

  • Dual Therapy Versus Monotherapy in the Endoscopic Treatment of High-Risk Bleeding Ulcers: A Meta-Analysis of Controlled Trials. Marmo, Riccardo; Rotondano, Gianluca; Piscopo, Roberto; Bianco, Maria A.; D'Angella, Rosario; Cipolletta, Livio // American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p279 

    BACKGROUND: There is no definite recommendation on the use of dual endoscopic therapy in patients with severe peptic ulcer bleeding. A systematic review and meta-analysis were performed to determine whether the use of two endoscopic hemostatic procedures improved patient outcomes compared with...

  • Treatment of Patients at High Risk for Recurrent Bleeding from a Peptic Ulcer. Jensen, Dennis M. // Annals of Internal Medicine;8/19/2003, Vol. 139 Issue 4, p294 

    Editorial. Focuses on treatment of patients at high risk for recurrent bleeding from a peptic ulcer. Effect of clots in patients with ulcer; Technique by which arteries less than 2 mm in diameter can be coagulated; Preferred treatment when endoscopy shows adherent clots and nonbleeding visible...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics